Pasar al contenido principal

AVANCES EN DIAGNOSTICO Y TERAPIA PARA ENFERMEDADES HEMATOLOGICAS HEREDITARIAS RARAS (ARETHA)

PID2021-122436OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT INTERNACIONAL DE CATALUNYA,FUNDACIO PRIVADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Pathological frataxin deficiency in mice causes tissue-specific alterations in iron homeostasis

  • Pazos Gil, Maria
  • Medina Carbonero, Marta
  • Sanz Alcázar, Arabela
  • Portillo-Carrasquer, Marta
  • Oliveira-Jorge, Luiza
  • Hernández, Gonzalo
  • Sánchez, Mayka
  • Delaspre, Fabien
  • Cabiscol Català, Elisa
  • Ros Salvador, Joaquim
  • Tamarit Sumalla, Jordi
Friedreich ataxia is caused by partial frataxin deficiency due to genetic mutations. It is well established that frataxin knockout affects iron homeostasis, but the alterations caused by pathological (partial) frataxin deficiency are poorly understood. In this study, we have analyzed iron homeostasis in a mouse model presenting pathological frataxin deficiency (FXNI151F). Our results reveal tissue-specific alterations of iron regulatory proteins (IRPs). In the heart, IRP2 accumulation is observed, likely triggered by iron-sulfur deficiency, while IRP1 is decreased in the cerebellum and liver. We also found elevated iron levels in mutant mice. Accumulation was particularly pronounced in the cerebellum, where increases were already evident at 10 weeks. Hepatic accumulation was not manifested until 21 weeks and was more pronounced in females. Overall, these findings indicate that frataxin deficiency disrupts iron homeostasis in a tissue-, age-, and sex-dependent manner, and provide novel insights into the mechanisms causing these perturbations., We thank Roser Pané for technical assistance, as well as the Proteomics and the Elemental Analysis Services from Universitat de Lleida, the Animal facilities from Universitat de Lleida, and the Lipidomics services from IRBLleida. We also thank Dr. Bruno Galy (Heidelberg) for providing samples from IRP2 KO mice. This study was supported by grant PID2020-118296RB-I00 from MCIN/AEI/10.13039/501100011033 (to J.R. and J.T.); grant PID2023-148128OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by FEDER, UE (to J.T. and E.C.); and grant PID2021-122436OB-I00 from MCIN/AEI/10.13039/501100011033/ERDF “A way to make Europe” (to M.S.), and by Association Française de l'Ataxie de Friedreich – AFAF (to F.D.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Pathological frataxin deficiency in mice causes tissue-specific alterations in iron homeostasis

  • Pazos Gil, Maria
  • Medina Carbonero, Marta
  • Sanz Alcázar, Arabela
  • Portillo-Carrasquer, Marta
  • Oliveira-Jorge, Luiza
  • Hernández, Gonzalo
  • Sánchez, Mayka
  • Delaspre, Fabien
  • Cabiscol Català, Elisa
  • Ros Salvador, Joaquim
  • Tamarit Sumalla, Jordi
Friedreich ataxia is caused by partial frataxin deficiency due to genetic mutations. It is well established that frataxin knockout affects iron homeostasis, but the alterations caused by pathological (partial) frataxin deficiency are poorly understood. In this study, we have analyzed iron homeostasis in a mouse model presenting pathological frataxin deficiency (FXNI151F). Our results reveal tissue-specific alterations of iron regulatory proteins (IRPs). In the heart, IRP2 accumulation is observed, likely triggered by iron-sulfur deficiency, while IRP1 is decreased in the cerebellum and liver. We also found elevated iron levels in mutant mice. Accumulation was particularly pronounced in the cerebellum, where increases were already evident at 10 weeks. Hepatic accumulation was not manifested until 21 weeks and was more pronounced in females. Overall, these findings indicate that frataxin deficiency disrupts iron homeostasis in a tissue-, age-, and sex-dependent manner, and provide novel insights into the mechanisms causing these perturbations., We thank Roser Pané for technical assistance, as well as the Proteomics and the Elemental Analysis Services from Universitat de Lleida, the Animal facilities from Universitat de Lleida, and the Lipidomics services from IRBLleida. We also thank Dr. Bruno Galy (Heidelberg) for providing samples from IRP2 KO mice. This study was supported by grant PID2020-118296RB-I00 from MCIN/AEI/10.13039/501100011033 (to J.R. and J.T.); grant PID2023-148128OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by FEDER, UE (to J.T. and E.C.); and grant PID2021-122436OB-I00 from MCIN/AEI/10.13039/501100011033/ERDF “A way to make Europe” (to M.S.), and by Association Française de l'Ataxie de Friedreich – AFAF (to F.D.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Haemochromatosis patients' research priorities: Towards an improved quality of life

  • Romero Cortadellas, Lídia
  • Venturi, Veronica
  • Martín-Sánchez, Juan Carlos
  • Toska, Ketil
  • Prince, Dianne
  • Butzeck, Barbara
  • Porto, Graça
  • Thorm Milman, Nils
  • HI/EFAPH Survey Committee
  • Sanchez-Fernandez, Mayka
Ministerio de Ciencia e Innovación, Grant/Award Number: RTC2019‐007074‐1; Generalitat de Catalunya, Grant/Award Number: 2020FI‐B00038; Agencia Estatal de Investigación, Grant/Award Number: PID2021‐122436OB‐I00; APU and ADISCON patient associations; UIC postdoctoral scholarship; RETOS COLABORACION Grant, Background: Chronic diseases are associated with a range of functional and psychosocial consequences that can adversely affect patients' quality of life (QoL). Haemochromatosis (HC) is a genetically heterogeneous disorder characterized by chronic iron overload that can ultimately lead to multiple organ dysfunction. Clinical diagnosis remains challenging due to the nonspecificity of symptoms and a lack of confirmatory genotyping in a substantial proportion of patients. Illness perception among HC patients has not been extensively investigated, lacking relevant information on how to improve their QoL. Methods: We present the results of the first worldwide survey conducted in nearly 1500 HC respondents, in which we collected essential demographic information and identified the aspects that concern HC patients the most. Results: Out of all the participants, 45.3% (n = 676) voiced their concern about physical and psychological consequences such as HC-related arthropathies, which can ultimately affect their social functioning. A similar proportion of patients (n = 635, 42.5%) also consider that better-informed doctors are key for improved HC disease management. Taking a patient-centred approach, we expose differences in patients' disease perspective by social and economic influences. Conclusions: We identify potential targets to improve patients' health-related QoL and reflect on strategic measures to foster gender equity in access to health resources. Finally, we make a call for a highly coordinated effort across a range of public policy areas to empower participants in the HC research process and design. Patient or Public Contribution: Nearly 1500 patients with hereditary HC responded to an anonymized online survey in which research and clinical priorities were addressed regarding this chronic and rare disease., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype

  • Maus, Mate
  • López Polo, Vanessa
  • Mateo, Lidia
  • Lafarga, Miguel
  • Aguilera, Mònica
  • De Lama, Eugenia
  • Meyer, Kathleen
  • SOLA, ANNA
  • Lopez-Martinez, Cecilia
  • López-Alonso, Ines
  • Guasch-Piqueras, Marc
  • Hernandez-Gonzalez, Fernanda
  • Chaib, Selim
  • Rovira, Miguel
  • Sanchez-Fernandez, Mayka
  • Faner, Rosa
  • Agusti, Alvar
  • Diéguez-Hurtado, Rodrigo
  • Ortega, Sagrario
  • Manonelles, Anna
  • Engelhardt, Stefan
  • Monteiro, Freddy
  • Stephan-Otto Attolini, Camille
  • Prats, Neus
  • M. Albaiceta, Guillermo
  • CRUZADO, JOSEP M
  • Serrano, Manuel
We are grateful to K. Raj (Altos Laboratories) for his help with the experiments on replicative senescence. We thank D. Muñoz Espin (University of Cambridge) for sending us the IMR90 cells stably transduced with tamoxifen inducible Ras-G12V. We thank R. Mendez (IRB) for the H5V and HUVEC cells. We thank staf at the TEM-SEM Electron Microscopy Unit from Scientific and Technological Centers (CCiTUB), Universitat de Barcelona for their support and advice on TEM techniques. We are thankful to the Magnetic Resonance Imaging Core Facility of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) for the scientific and technical support in MRI acquisition and analysis. M.M. received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement (no. 794744) and from the Spanish Ministry of Science and Innovation (MCIN) (RYC2020-030652-/AEI/10.13039/501100011033). V.L.P. was a recipient of a predoctoral contract from the Spanish Ministry of Education (FPU-18/05917). K.M. was a recipient of fellowships from the German Cardiac, the German Research Foundation and a postdoctoral contract Juan de la Cierva from the MCIN. F.H.G. was supported by the PhD4MD Collaborative Research Training Program for Medical Doctors (IRB Barcelona/Hospital Clinic/IDIBAPS). M. Sanchez was funded by grants PID2021-122436OB-I00 from MCIN/AEI/10.13039/501100011033/FEDER, UE, RETOS COLABORACION RTC2019-007074-1 from MCIN/AEI/10.13039/501100011033. C.L.-M. was a recipient of a predoctoral contract from the Spanish Ministry of Education (FPU-18/02965). G.A. was funded by the Instituto de Salud Carlos III through project PI 20/01360, FEDER funds. J.M.C. was funded by the Instituto de Salud Carlos III through projects PI18/00910 and PI21/00931 (co-funded by European Regional Development Fund, a way to build Europe) and thanks the CERCA Programme/Generalitat de Catalunya for institutional support. Work in the laboratory of M. Serrano was funded by the IRB and ‘laCaixa’ Foundation and by grants from the Spanish Ministry of Science co-funded by the European Regional Development Fund (SAF2017-82613-R), European Research Council (ERC-2014-AdG/669622) and grant RETOS COLABORACION RTC2019-007125-1 from MCIN/AEI and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282)., Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases. Senescent cells are a main driver of fibrotic diseases through their secretome, known as senescence-associated secretory phenotype (SASP). Here, we report that cellular senescence, and multiple types of fibrotic diseases in mice and humans are characterized by the accumulation of iron. We show that vascular and hemolytic injuries are efficient in triggering iron accumulation, which in turn can cause senescence and promote fibrosis. Notably, we find that senescent cells persistently accumulate iron, even when the surge of extracellular iron has subdued. Indeed, under normal conditions of extracellular iron, cells exposed to different types of senescence-inducing insults accumulate abundant ferritin-bound iron, mostly within lysosomes, and present high levels of labile iron, which fuels the generation of reactive oxygen species and the SASP. Finally, we demonstrate that detection of iron by magnetic resonance imaging might allow non-invasive assessment of fibrotic burden in the kidneys of mice and in patients with renal fibrosis. Our findings suggest that iron accumulation plays a central role in senescence and fibrosis, even when the initiating events may be independent of iron, and identify iron metabolism as a potential therapeutic target for senescence-associated diseases., info:eu-repo/semantics/publishedVersion